Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”
Liver Cancer · 06.04.2026 · 1-2
DOI: 10.1159/000551853 ↗Kurz gefasst
Leserbrief in der Zeitschrift Liver Cancer, online erschienen am 06.04.2026. Verfasst von Mulin Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China.
- Department of Obstetrics and Gynecology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Zitieren
APA
Liu, M., Zheng, Q., & Fu, J. (2026). Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”. Liver Cancer, 1-2. https://doi.org/10.1159/000551853
Vancouver
Liu M, Zheng Q, Fu J. Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”. Liver Cancer. 2026:1-2. doi:10.1159/000551853
BibTeX
@article{Liu2026,
author = {Liu, Mulin and Zheng, Qin and Fu, Juan},
title = {Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”},
journal = {Liver Cancer},
year = {2026},
pages = {1--2},
doi = {10.1159/000551853}
}
EUVIMED